BridgeMD
New treatment option for Stroke
Official title Reduction of Recurrence of Stroke by Nurse-led Education in Bangladesh
ClinicalTrials.gov ID: NCT05520034
What this study is testing
- What it's testing
- Stroke is a major public issue that can be occurred a patient with severe and unbearable disability for a long time. Recurrence of stroke is increasing due to a lack of knowledge and compliance with treatment regarding the modifiable risk factors of stroke and behavioral and lifestyle changes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- For patient
- Who was discharged from NINSH to home or who visited NINSH right after getting a stroke
- First-time stroke
- All types of strokes, except subarachnoid haemorrhage
- modified Rankin Scale (0 - 4)
You likely can't join if
- Exclusion criteria of patient
- Who has stroke with the recurrence
- Stroke subtype: caused by genetic problems or injury/accident
- Patients with multi-organ failure or terminal stage
- Participation in other clinical trials
- Unwillingness to participate in the study
See the full eligibility criteria
- For patient
- Who was discharged from NINSH to home or who visited NINSH right after getting a stroke
- First-time stroke
- All types of strokes, except subarachnoid haemorrhage
- modified Rankin Scale (0 - 4)
- Stroke patient who is 18 years old and above
- Both males \& females
- Who provided written consent \& willing to participate in the study For family caregivers
- Primary caregivers irrespective of sex and aged 18 years old and above, living with the patient who take care of an above patient and who meets all of the (will be decided by one person)
- Who will provide written consent \& willing to participate in the study
- Exclusion criteria of patient
- Who has stroke with the recurrence
- Stroke subtype: caused by genetic problems or injury/accident
- Patients with multi-organ failure or terminal stage
- Participation in other clinical trials
- Unwillingness to participate in the study
- Not having a mobile phone at home
- mRS 5 Exclusion criteria of caregiver
- Who is not living with the patient
- Who is under 18 years old
- Who is mentally unstable and/or cognitively impaired (diagnosed cases)
The study team makes the final eligibility decision.
Where it's taking place
- Dhaka, Bangladesh
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dhaka, Bangladesh. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.